Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

Abstract Background Percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) remains challenging even with modern drug-eluting stents (DES) due to high rates of repeat revascularization. Everolimus-eluting bioresorbable scaffolds (EE-BRS) might allow for repeat intervention p...

Full description

Bibliographic Details
Main Authors: T. M. Hommels, R. S. Hermanides, S. Rasoul, B. Berta, A. J. J. IJsselmuiden, G. A. J. Jessurun, E. Benit, B. Pereira, G. De Luca, E. Kedhi
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Cardiovascular Diabetology
Subjects:
Bioresorbable scaffold
Diabetes mellitus
Coronary artery disease
Percutaneous coronary intervention
Scaffold thrombosis
Online Access:http://link.springer.com/article/10.1186/s12933-019-0827-z

Internet

http://link.springer.com/article/10.1186/s12933-019-0827-z

Similar Items